The American Academy of Neurology strives to promote the highest quality patient-centered neurologic care and enhance member career satisfaction.
To that end, a in partnership with the ALS Association and American Brain Foundation, the academy welcomes applications for the Richard Olney Clinician Scientist Development Award in ALS program. Through the program, young investigators conducting clinical studies in ALSare awarded $75,000 a year for three years, as well as a $5,000 per year stipend for education- and research-related costs.
Projects of interest to the academy include patient-oriented research conducted with human subjects or translational research specifically designed to develop treatments or enhance diagnosis for ALS. Areas of research may include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, or health services and outcomes research. Disease-related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools aimed at preventing or mitigating ALS.
To be eligible, applicants must be an AAN member interested in an academic career in neurological research who has completed his/her residency or a PhD no more than seven years prior to the beginning of the award period (July 1, 2021).
See the American Academy of Neurology website for complete program guidelines and application instructions.